Associated Papers
Fibroblast growth factor receptor 3 mutation attenuates response to immune checkpoint blockade in metastatic urothelial carcinoma by driving immunosuppressive microenvironment.
Song Y et al.
Journal for Immunotherapy of Cancer, 2023
37777251 (PubMed )
Supplement: jitc-2022-006643supp001.pdf
Select a paper to view details